JPB has served as a consultant for several pharmaceutical companies, including Amgen, Sanofi, Eli Lilly, Merck, Janssen, Pfizer, and Takeda. JPB serves as the Director of the Center for Protein Therapeutics, which is sponsored by AbbVie, Amgen, AstraZeneca, CSL-Behring, Eli Lilly, Genentech, Glaxosmithkline, Janssen, Merck, Roche, Sanofi, and Seagen. JPB receives research support from the Center for Protein Therapeutics and from the National Institutes of Health (CA246785, CA256928, CA261343, CA275967). JPB is a co-founder of Abceutics, Inc., a biotechnology company involved in the development of antibody fragment drugs, and JPB reports patents relating to the discovery and use of monoclonal antibody drugs.